Monopar Therapeutics Inc. (MNPR)
NASDAQ · Healthcare
Monopar Therapeutics Inc. Net Income 2016–2025
Monopar Therapeutics Inc. annual/quarterly net income history and growth rate from 2016 to 2026. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.
- Monopar Therapeutics Inc. net income for the quarter ending March 31, 2026 was -3.9 M, a 182.88% increase year-over-year.
- Monopar Therapeutics Inc. net income for the twelve months ending March 31, 2026 was -6.9 M, a 59.43% decrease year-over-year.
- Monopar Therapeutics Inc. annual net income for 2025 was -13.7 M, a 11.99% decrease from 2024.
- Monopar Therapeutics Inc. annual net income for 2024 was -15.6 M, a 268.92% increase from 2019.
- Monopar Therapeutics Inc. annual net income for 2019 was -4.2 M, a 30.88% increase from 2018.
- Monopar Therapeutics Inc. annual net income for 2018 was -3.2 M.
Net Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Monopar Therapeutics Inc. Net Income — FAQ
Monopar Therapeutics Inc. (MNPR) net income over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
What is Monopar Therapeutics Inc.'s net income?
Monopar Therapeutics Inc. (MNPR) reported net income of -$14M for fiscal 2025.
Where can I see MNPR's net income history?
The chart and table above show Monopar Therapeutics Inc.'s net income by year and by quarter, including the growth rate.